About Neurapy
Neurapy is a Healthcare company based in Chennai (India) founded in 2018 by Madan Kumar Govindarajan and Pushparaja S. It provides software for vision therapy to treat eye issues at home and clinics. It operates on a B2B and B2C model. Its chief executive is Madan Kumar Govindarajan. Its Indian entity Neurapy Private Limited reported revenue of ₹33.8 Lakh. Neurapy offers products and services including VisuoPrime Home Edition, VisuoPrime Professional Edition, and OptoPrime Professional Edition. Its focus areas include Consumer Health, Digital Therapy, Eye Care and Home-Based Tools. Its competitors include Radius XR, 2EyesVision, Myopia, Olympic Ophthalmics and Optimo Medical and 4 more; 2 of its 9 listed competitors have raised funding.
Company details
Neurapy develops specialized software and tools for vision therapy, focusing on conditions like Amblyopia and Strabismus. They provide home-based editions for patient use under doctor guidance with cloud monitoring, and professional editions for clinics to diagnose and treat eye problems. The company enables customized prescriptions and immersive experiences, collaborating with healthcare professionals to improve vision care through innovative technology.
- Headquarters Chennai, India
- Founders Madan Kumar Govindarajan, Pushparaja S
- SectorsHealthcare
- Website neurapy.com
- Legal Name Neurapy Private Limited
- Date of Incorporation 20 Sep, 2018
- Jurisdiction Chennai, Tamil Nadu, India
- Annual Revenue₹33.8 Lakh
FY 2024 · -25% YoY
- Net Profit₹7.2 Lakh
FY 2024 · 21% margin
- EBITDA₹8.7 Lakh
FY 2024 · 26% margin
Associated legal entities of Neurapy
Neurapy operates through Neurapy Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2024) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Neurapy Private Limited CIN U74999TN2018PTC124736 | Active | 20 Sep 2018 | Chennai, Tamil Nadu | ₹0.3 Cr | – | 3 | View details |
Products & Services of Neurapy
Neurapy offers a comprehensive portfolio of products and services, including VisuoPrime Home Edition, VisuoPrime Professional Edition, and OptoPrime Professional Edition.
Software for treating eye problems at home with doctor guidance.
Software to diagnose and treat eye issues in clinical settings.
VR-based tools for advanced treatment of vision problems.
Board of directors of Neurapy Private Limited (Neurapy)
Neurapy Private Limited is the primary company behind Neurapy. The board of Neurapy Private Limited currently have 3 directors; the longest-serving is Govindarajan Madan Kumar, appointed in 2018. 2 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Govindarajan Madan Kumar DIN 08232491 | Director | 20 Sep 2018 | 8 yrs 1 mo | Neurapy Private Limited |
| Adithya Goyal DIN 08232490 | Director | 20 Sep 2018 | 8 yrs 1 mo | Neurapy Private Limited |
| Kanchana Sankaranarayanan DIN 10943702 | Director | 10 Feb 2025 | 1 yr 8 mo | Neurapy Private Limited |
People of Neurapy
2 people are tracked at Neurapy (2 in leadership).
| Name | Role | Group |
|---|---|---|
| Co-Founder, CEO | Leadership | |
Pushparaja S | Co-Founder, CTO | Leadership |
Complete people profiles for Neurapy
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Neurapy
Figures of Neurapy Private Limited, the primary company behind Neurapy, for FY 2024. Revenue was ₹33.8 Lakh (-25% year on year). Net profit was ₹7.2 Lakh (21% margin). EBITDA was ₹8.7 Lakh (26% margin). Revenue has grown at a compounded annual rate of +60% over three years and +38% over five years.
- ₹33.8 LakhRevenue · FY 2024 · -25% YoY
- ₹7.2 LakhNet profit · 21% margin
- ₹8.7 LakhEBITDA · 26% margin
- ₹1.2 LakhPaid-up capital
- +60%Revenue CAGR, 3 years
- +38%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Neurapy Private Limited are on its company page.
Detailed financial statements for Neurapy
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Competitors of Neurapy
Neurapy has 9 listed competitors in our database, 2 of them funded. They include Radius XR, 2EyesVision, Myopia, Olympic Ophthalmics and Optimo Medical, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| radiusxr.com | 2017 | Pleasanton, United States | – | – | Provider of wearable patient engagement and diagnostic system | |
| 2eyesvision.com | 2015 | Madrid, Spain | $100,000 | – | Portable technologies for multifocal eye corrections before surgeries are developed. | |
| myopia.app | 2018 | Aguilas, Spain | – | – | Myopia prevention app monitors family screen habits and distances. | |
| olympicophthalmics.com | 2020 | Issaquah, United States | – | – | Provider and developer of tear production device for treatments of dry eye disease | |
| optimo-medical.com | 2015 | – | $1.95M | – | Delivers digital software for cornea detection in healthcare settings. | |
| binovi.com | 2011 | Oakville, Canada | – | – | Provides software-based solutions for vision therapy plan to optometry professionals and patients | |
| ocumetra.com | 2020 | Dublin, Ireland | – | – | Provider of myopia treatment analytics software | |
| csidryeye.com | 2019 | Calgary, Canada | – | – | AI-based platform for dry eye diagnosis, treatment, and management for doctors. | |
| myocalc.info | 2022 | Renens, Switzerland | – | – | Web platform for calculating and managing myopia progression in children. |
Detailed competitors of Neurapy
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Digital Health & Telemedicine
10 companies that operate in the same segment as Neurapy (Digital Health & Telemedicine), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Provider of an online pharmacy with doctor listing and teleconsultation services | 2015 | Delhi, Delhi, India | USD 230.8 M | USD 328.97 M | 5,212 | |
Online platform offering multiple healthcare services | 2013 | Bengaluru, Karnataka, India | USD 199.22 M | USD 62.4 M | 52 | |
An application is provided for comparing prescription drug prices nationwide. | 2011 | Santa Monica, California, United States | USD 22.21 M | USD 796.85 M | 1,063 | |
Healthcare appointments are booked online via Zocdoc's platform. | 2007 | New York, New York, United States | USD 425.97 M | USD 4.66 M | 1,365 | |
An online marketplace for healthcare products is operated. | 2011 | Kolkata, West Bengal, India | USD 38.26 M | – | – | |
Alto Pharmacy is focused on providing convenient prescription delivery services. | 2015 | San Francisco, California, United States | USD 591.64 M | – | 802 | |
Membership-based primary care platform is offered for employees and consumers. | 2007 | San Francisco, California, United States | USD 402.56 M | – | – | |
Telehealth solutions are provided for doctors and patients' consultations. | 2006 | Boston, Massachusetts, United States | USD 887.35 M | USD 115.54 M | 742 | |
Digital health services for men's wellness are offered by Ro. | 2017 | New York, New York, United States | USD 1.03 B | – | 1,485 | |
Provider of genetic test solutions to study ancestry, genealogy, and inherited traits | 2006 | Sunnyvale, California, United States | USD 943.53 M | USD 189.9 M | 562 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Neurapy
Neurapy was founded in 2018.
Neurapy is headquartered in Chennai, India. It is registered at Chennai, Tamil Nadu, India.
Madan Kumar Govindarajan is the current CEO of Neurapy. They have also founded this company.
The primary company behind Neurapy, Neurapy Private Limited, reported revenue of ₹33.8 Lakh for FY 2024, down 25% year on year.
Neurapy develops specialized software and tools for vision therapy, focusing on conditions like Amblyopia and Strabismus. They provide home-based editions for patient use under doctor guidance with cloud monitoring, and professional editions for clinics to diagnose and treat eye problems. The company enables customized prescriptions and immersive experiences, collaborating with healthcare professionals to improve vision care through innovative technology.
Neurapy's top competitors include 2EyesVision, Myopia and Radius XR.
Neurapy offers VisuoPrime Home Edition, VisuoPrime Professional Edition, and OptoPrime Professional Edition.
Neurapy operates through Neurapy Private Limited.
The legal entities of Neurapy currently have 3 directors, including Govindarajan Madan Kumar, Adithya Goyal, Kanchana Sankaranarayanan.